ArticleiScience2023
IL-24 is the key effector of Th9 cell-mediated tumor immunotherapy.
Jintong Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleiScience2023
Jintong Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.